VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $19,835,000 | -24.0% | 1,245,919 | -0.8% | 1.06% | -21.1% |
| Q4 2017 | $26,094,000 | +76.4% | 1,255,723 | +21.6% | 1.34% | +72.0% |
| Q3 2017 | $14,796,000 | -17.0% | 1,032,553 | +0.3% | 0.78% | -20.0% |
| Q2 2017 | $17,817,000 | +84.9% | 1,029,857 | +17.9% | 0.98% | +79.1% |
| Q1 2017 | $9,634,000 | -51.2% | 873,445 | -35.8% | 0.54% | -2.3% |
| Q4 2016 | $19,758,000 | +13.0% | 1,360,702 | +91.0% | 0.56% | +3.0% |
| Q3 2016 | $17,488,000 | +24.7% | 712,336 | +2.3% | 0.54% | +17.8% |
| Q2 2016 | $14,020,000 | -4.0% | 696,104 | +25.3% | 0.46% | -1.9% |
| Q1 2016 | $14,606,000 | -70.8% | 555,338 | +12.8% | 0.47% | -69.8% |
| Q4 2015 | $50,058,000 | – | 492,456 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |